- Recent Funding
- Investors
- DaVita Venture Group
DaVita Venture Group portfolio
DaVita Venture Group has 4 portfolio companies on record at Recent Funding, with 2 investments in the last 12 months.
About this page
It led 1 of the 5 rounds it joined. Its most recent investment on record is R1 Therapeutics's $77.5M Series A round in March 2026, which it led, alongside U.S. Renal Care, Abingworth, SymBiosis and 2 others. By category, its portfolio leans toward Health and bio (4) and Consumer and social (1). It has co-invested with Abingworth, Catalys Pacific and SymBiosis, most often Abingworth (2 rounds).
What DaVita Venture Group invests in
- Health and bio · 4 · 100%
- Consumer and social · 1 · 25%
- Fintech · 1 · 25%
- Insurance · 1 · 25%
DaVita Venture Group recent investments
| Company | Round | Date | Alongside |
|---|---|---|---|
| Series A · $77.5M · lead | U.S. Renal Care, Abingworth (lead), SymBiosis +2 | ||
| Series B+ · $33M | Flare Capital Partners, Health Velocity Capital, Granite Financial Holdings +5 | ||
| Series B+ · $105M | Marshall Wace, TCG Crossover (lead), Samsara Biocapital +4 | ||
| Series A · $150M | The Carlyle Group, Abingworth (lead), Catalys Pacific +1 | ||
| Series A · $10M | MBX Capital, Rock Health Capital, CD-Venture +6 |
How DaVita Venture Group invests
DaVita Venture Group portfolio companies
RR1 Therapeutics$77.5MSeries A · Mar 2026
GGreater Good Health$33MSeries B+ · Mar 2026
PPathalys$105MSeries B+ · Aug 2024
WWellth$10MSeries A · May 2020
| Company | Round with DaVita Venture Group | Total raised | Latest raise |
|---|---|---|---|
Health and bio |
Series A · $77.5M · lead | $158M | Sep 30, 2026 Series A |
Health and bio |
Series B+ · $33M | $53M | Mar 5, 2026 Series B+ |
Health and bio |
Series B+ · $105M | $255M | Aug 20, 2024 Series B+ |
Fintech |
Series A · $10M | $73M | Sep 15, 2025 Series B+ |
Most frequent co-investors
AAbingworth2 shared rounds · last Mar 17, 2026
CCatalys Pacific2 shared rounds · last Aug 20, 2024
SSymBiosis1 shared round · last Mar 17, 2026
FF-Prime Capital1 shared round · last Mar 17, 2026
UU.S. Renal Care1 shared round · last Mar 17, 2026
CCurie.Bio1 shared round · last Mar 17, 2026
FFlare Capital Partners1 shared round · last Mar 5, 2026
HHealth Velocity Capital1 shared round · last Mar 5, 2026
MMartin Ventures1 shared round · last Mar 5, 2026
LLRVHealth1 shared round · last Mar 5, 2026
OOptum Ventures1 shared round · last Mar 5, 2026
- GGranite Financial Holdings1 shared round · last Mar 5, 2026
Similar investors
AAble Partners4 companies · 1 deal in 12 mo
GGenoa Ventures5 companies · 4 deals in 12 mo
BBdc Thrive venture5 companies · 3 deals in 12 mo
CCatalyst Health Ventures5 companies · 3 deals in 12 mo
NNPIF – Mercia Equity Finance5 companies · 3 deals in 12 mo
VVirginia Innovation Partnership Corporation5 companies · 3 deals in 12 mo
Investors whose portfolios on Recent Funding center on the same category (Health and bio).
How this is counted
Share is of the 5 rounds on Recent Funding that name DaVita Venture Group. Rounds with no announced date are left out of the year split, and "round" is a round whose stage is not on file.
Portfolio companies are the companies on Recent Funding with a round that lists DaVita Venture Group, which is a subset of its real portfolio. API: /api/v1/investors/davita-venture-group (get a free API key). More: the most active VC firms and new venture capital funds.